// you’re reading...

General Biotechnology

IPO market abuzz with biotech offerings

IPO market abuzz with biotech offerings
The buzz is biotech — at least as far as initial public offerings are concerned in the fourth quarter.

Discussion

No comments for “IPO market abuzz with biotech offerings”

Post a comment